N-methyl-1-(2-thiophen-2-ylphenyl)methanamine

N-methyl-1-(2-thiophen-2‑ylphenyl)methanamine is a synthetic small molecule belonging to the phenylmethylamines class. It has been investigated as an experimental compound and is not approved for clinical use. Its primary mechanism of action is as an inhibitor of leukotriene A4 hydrolase (LTA4H), an enzyme involved in the biosynthesis of leukotriene B4, a pro-inflammatory mediator in the arachidonic acid pathway. By inhibiting LTA4H, this compound may modulate inflammatory responses and has been explored as a discovery agent in preclinical research settings[1][4]. There are no known approved indications or marketed formulations.

Other names

N-Methyl-N-(2-thien-2-ylbenzyl)amineBenzenemethanamine, N-methyl-2-(2-thienyl)-N-methyl-N-(2-thiophen-2'-ylbenzyl)aminemethyl[(2-(2-thienyl)phenyl)methyl]amine